S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2020-04	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Swain, Sandra M.; Miles, David; Kim, Sung-Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefania; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortes, Javier; CLEOPATRA study group; Oh, Do Youn The Lancet Oncology, Vol.21 No.4, pp.519-530	DOI
2021-01	Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study Tan, Antoinette R.; Im, Seock-Ah; Mattar, Andre; Colomer, Ramon; Stroyakovskii, Daniil; Nowecki, Zbigniew; De laurentiis, Michelino; Pierga, Jean-Yves; Jung, Kyung Hae; Schem, Christian; Hogea, Alexandra; Crnjevic, Tanja Badovinac; Heeson, Sarah; Shivhare, Mahesh; Kirschbrown, Whitney P.; Restuccia, Eleonora; Jackisch, Christian The Lancet Oncology, Vol.22 No.1, pp.85-97	DOI